Accessibility Statement – Clinical One Research

Accessibility Statement

Clinical One Research is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards to enhance usability and inclusivity.

Measures to Support Accessibility

Clinical One Research takes the following measures to ensure accessibility of our website:

Regular audits of web content for accessibility compliance.
Implementation of accessibility best practices in design and development.
Ongoing staff training on inclusive digital communication.
Prompt response to accessibility feedback or issues.

Conformance Status

The Web Content Accessibility Guidelines (WCAG) define requirements for designers and developers to improve accessibility for people with disabilities. Clinical One Research aims to conform to WCAG 2.1 Level AA standards.

We are actively working to ensure that all content on our website is accessible to users with visual, auditory, cognitive, and motor impairments.

Accessibility Features

Alternative text for all meaningful images.
Keyboard navigability throughout the website.
Sufficient color contrast for text and UI elements.
Descriptive link text.
Semantic HTML to aid screen readers.

Feedback

We welcome your feedback on the accessibility of Clinical One Research. If you encounter any accessibility barriers or need assistance, please contact us:

Phone: 407-594-5444
Email: info@clinicaloneresearch.com
Contact Form: Click Here

We aim to respond to accessibility inquiries within 5 business days.

Limitations and Alternatives

While we strive to ensure full accessibility, some content may not yet fully meet the highest accessibility standards. In such cases, we are happy to provide alternative formats or support upon request.

Date

This accessibility statement was last reviewed on: May 30, 2025.

Seela Ramesh, MD

Dr. Ramesh is a board-certified Gastroenterologist with extensive expertise in Advanced and Therapeutic Endoscopy, ERCP, Endoscopic Ultrasonography (EUS), and the management of liver diseases. He completed his medical education at the Medical College of Virginia, an institution globally recognized for its excellence in Gastroenterology and Hepatology.

A highly experienced Principal Investigator, Dr. Ramesh has led numerous clinical trials across a wide range of therapeutic areas, including hepatology, inflammatory bowel disease (IBD), and metabolic liver disorders. His research contributions have helped advance innovative treatments, and he has been published in leading peer-reviewed journals. His work includes studies on hepatitis C, nonalcoholic fatty liver disease (NAFLD), and the role of cannabinoid receptors in hepatic metabolism.

Dr. Ramesh’s publications and presentations include:

Ramesh, S., & Sanyal, A. J. (2004). Hepatitis C and nonalcoholic fatty liver disease. Seminars in Liver Disease, 24(4), 399-413.
Ramesh, S., & Sanyal, A. J. (2005). Evaluation and management of non-alcoholic steatohepatitis. Journal of Hepatology, 42(1), S2-S12.
Ramesh, S., Mirashi, F., Choudhoury, J., & Sanyal, A. J. (2005). Cannabinoids block interferon-mediated suppression of hepatitis C virus replicon. AASLD, Poster Presentation.
Ramesh, S., Mirashi, F., Choudhoury, J., Gupta, S., & Sanyal, A. J. (2005). Methanandamide promotes hepatic lipogenesis by increasing SREBP-1 and SREBP-2 activity—a novel effect of cannabinoid (CB1) receptor activation. AASLD, Poster Presentation.
Qasem, A., Ramesh, S., & Naser, S. A. (2018). Role of TNF antagonists in susceptibility to mycobacterial infection in association with genetic polymorphisms in Crohn's disease. UCD Biomedical Sciences Annual Graduate Research Symposium, Poster Presentation.

Dr. Ramesh is a Clinical Assistant Professor of Medicine at the University of Central Florida and plays an active role in training medical professionals at Osceola Regional Medical Center. He is also a distinguished member of professional organizations, including the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE), the American Association for the Study of Liver Diseases (AASLD), and the Crohn’s & Colitis Foundation (CCF).

With a strong background in clinical research, protocol development, and investigational therapies, Dr. Ramesh is dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials.